The disease course of multiple sclerosis before and during COVID-19 pandemic: a retrospective five-year study

F Babtain, A Bajafar, O Nazmi, M Badawi… - Multiple Sclerosis and …, 2022 - Elsevier
Introduction COVID-19 pandemic is thought to influence the natural history of immune
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …

[HTML][HTML] The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study

F Babtain, A Bajafar, O Nazmi, M Badawi… - Multiple Sclerosis and …, 2022 - ncbi.nlm.nih.gov
Results We studied 301 patients; 216 (72%) were women, the mean age was 38 years
(range; 16, 73 years), the mean disease duration was 10 years (range; 1, 36 years), and the …

The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study

F Babtain, A Bajafar, O Nazmi, M Badawi… - Multiple Sclerosis …, 2022 - msard-journal.com
Introduction COVID-19 pandemic is thought to influence the natural history of immune
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …

The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study

F Babtain, A Bajafar, O Nazmi… - Multiple sclerosis …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction COVID-19 pandemic is thought to influence the natural history of immune
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …

The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study.

F Babtain, A Bajafar, O Nazmi, M Badawi… - Multiple Sclerosis and …, 2022 - europepmc.org
Results We studied 301 patients; 216 (72%) were women, the mean age was 38 years
(range; 16, 73 years), the mean disease duration was 10 years (range; 1, 36 years), and the …